Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02469701
Title BrUOG 317: Nivolumab and Ablation For Patients With Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors howard safran
Age Groups: adult
Covered Countries USA

No variant requirements are available.